NOVAVAX INC's ticker is NVAX and the CUSIP is 670002401. A total of 446 filers reported holding NOVAVAX INC in Q3 2021. The put-call ratio across all filers is 1.27 and the average weighting 0.1%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q1 2022 | $3,082,000 | -41.2% | 41,853 | +14.2% | 0.00% | -25.0% |
Q4 2021 | $5,242,000 | -96.6% | 36,641 | -95.1% | 0.00% | -97.5% |
Q3 2021 | $154,236,000 | +5939.0% | 743,986 | +5181.4% | 0.16% | +3975.0% |
Q1 2021 | $2,554,000 | +102.9% | 14,087 | -6.7% | 0.00% | +33.3% |
Q2 2020 | $1,259,000 | – | 15,106 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
HELLMAN JORDAN MANAGEMENT CO INC /MA/ | 50,910 | $5,516,000 | 10.50% |
DISCOVERY CAPITAL MANAGEMENT, LLC / CT | 297,400 | $32,223,000 | 4.94% |
Ikarian Capital, LLC | 375,400 | $40,675,000 | 2.94% |
TSP Capital Management Group, LLC | 60,075 | $6,509,000 | 2.66% |
RA Capital Management | 1,198,602 | $129,869,000 | 2.38% |
Foresite Capital Management I, LLC | 66,810 | $7,239,000 | 2.04% |
Healthcare Value Capital, LLC | 5,000 | $542,000 | 1.79% |
Rock Springs Capital Management LP | 585,705 | $63,461,000 | 1.61% |
Foresite Capital Management II, LLC | 67,373 | $7,300,000 | 1.59% |
BERYLSON CAPITAL PARTNERS, LLC | 30,104 | $3,262,000 | 1.14% |